Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Adrenergic receptors in rat brain.

J R Sporn, P B Molinoff

    Journal of Cyclic Nucleotide Research
    |January 1, 1976
    PubMed
    Summary

    125I-Iodohydroxybenzylpindolol ([125I] IHYP) is a reliable radioligand for studying beta-adrenergic receptors in rat brain regions. Its binding properties are consistent with specific interaction with these receptors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.

    International journal of impotence research·2004
    Same author

    Common to both academia and industry: the challenge of discovery. An interview with Perry Molinoff.

    Molecular interventions·2004
    Same author

    Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.

    International journal of impotence research·2004
    Same author

    PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

    Annals of the New York Academy of Sciences·2003
    Same author

    Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

    Nature medicine·2001
    Same author

    Reversible granulocytopenia in association with riluzole therapy.

    The Annals of pharmacotherapy·2000

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Biochemistry

    Background:

    • Beta-adrenergic receptors play crucial roles in the central nervous system.
    • Understanding the distribution and characteristics of these receptors is vital for neurological research.

    Purpose of the Study:

    • To characterize the binding properties of 125I-Iodohydroxybenzylpindolol ([125I] IHYP) as a radioligand for beta-adrenergic receptors in rat brain.
    • To determine the density and distribution of these binding sites in different brain regions.

    Main Methods:

    • Radioligand binding assays using [125I] IHYP on rat brain membrane fractions.
    • Competition binding studies with adrenergic agonists and antagonists.
    • Scatchard analysis to determine binding site density (K(D)) and affinity.

    Main Results:

    • [125I] IHYP demonstrated specific binding to beta-adrenergic receptors, with rapid association and dissociation kinetics.
    • Phentolamine did not affect specific binding, while dl-propranolol effectively blocked it.
    • Binding affinity (K(D)) was consistent across cerebral cortex, cerebellum, and caudate nucleus.
    • The density of binding sites was higher in the cortex and caudate compared to the cerebellum.
    • Stereoisomers showed significant differences in potency, with 1-isomers being more potent than d-isomers.

    Conclusions:

    • [125I] IHYP is a suitable radioligand for quantitative studies of beta-adrenergic receptors in the rat brain.
    • The study provides insights into the regional distribution of beta-adrenergic receptors in the rat brain.

    Related Experiment Videos